search
Back to results

Chinese Smartphone App for 6-18 Years With T1DM - RCT

Primary Purpose

Type1 Diabetes Mellitus

Status
Recruiting
Phase
Not Applicable
Locations
Hong Kong
Study Type
Interventional
Intervention
Intervention arm - A new smartphone application for pediatric type 1 DM
Standard diabetic eduction
Sponsored by
Chinese University of Hong Kong
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Type1 Diabetes Mellitus

Eligibility Criteria

6 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Known type 1 DM diagnosed for at least 6 months
  2. Aged 6-18 years
  3. HbA1c >/= 6.0% in the preceding 6 months prior to recruitment
  4. Receiving DM care in Hong Kong

Exclusion Criteria:

  1. Lack of the ability to use a smartphone application despite an introduction session the smartphone application intended for this study
  2. Moderate to severe visual impairment that may affect the smartphone application usage
  3. Cannot read Chinese language.

Sites / Locations

  • Hong Kong Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Intervention Arm - Use of the new smartphone application for T1DM

Control Arm - Standard diabetic education

Arm Description

The use of the locally designed smartphone application for T1DM for 6 months, which contained the following domains: Type 1 DM self-management information and decision-making algorithm Carbohydrate counting information on local food in Hong Kong DM day-to-day troubleshooting psychosocial scenarios Game-based interactive tools for DM knowledge enhancement Usage tracking for each domain of the smartphone application Individual participant identification and access code (known to research assistant)

Received standard diabetic care (diabetic nurse education and regular follow-ups) with optional use of an existing smartphone application for general diabetic information for both adult and pediatric population (that encompasses both information for type 1 and type 2 DM)

Outcomes

Primary Outcome Measures

HbA1c
A decrease of 0.5% is considered significant
CGM data
Time in range, glycemic variability and percentage of hypoglycemia as documented by continuous glucose monitoring (for a period of 2 weeks) at baseline and at the end of study.
Self/Parent-reported questionnaires on hypoglycemia frequency
Self/Parent-reported questionnaires on hypoglycemia frequency, the lowest glucose reading during hypoglycemia and number of severe hypoglycemia requiring glucagon use - to be performed at baseline and at the end of study.

Secondary Outcome Measures

The PSC-35 (Pediatric Symptom Checklist-35 items) questionnaires
The PSC-35 (Pediatric Symptom Checklist-35 items) questionnaires is employed to assess the psychological wellbeing at baseline and at the end of study.
The Chinese version of the Diabetes Self-Management Questionnaire (DSMQ)
The Chinese version of the Diabetes Self-Management Questionnaire (DSMQ) is employed to assess the diabetes self-management behavior at baseline and at the end of study. The data on the questionnaire's use in youths or children are not available yet. We will interpret with caution for those questions not entirely applicable to participants <18 years.
The Chinese version of the Pediatric Quality of Life Inventory 4.0 plus the 3.0 diabetes module
The Chinese version of the Pediatric Quality of Life Inventory 4.0 plus the 3.0 diabetes module to be filled in at baseline and at the end of study.Diabetes module will not be required for participants with ages 5-7 years as Chinese version is currently not available.
Self/Parent-reported questionnaires to assess on carbohydrate counting accuracy on local Hong Kong diet at baseline and at the end of study
Self/Parent-reported questionnaires to assess on carbohydrate counting accuracy on local Hong Kong diet at baseline and at the end of study
Self-reported smartphone application usage satisfaction
Self-reported smartphone application usage satisfaction to be filled at 3 months and the end of study.

Full Information

First Posted
May 29, 2022
Last Updated
June 12, 2022
Sponsor
Chinese University of Hong Kong
search

1. Study Identification

Unique Protocol Identification Number
NCT05418569
Brief Title
Chinese Smartphone App for 6-18 Years With T1DM - RCT
Official Title
The Impact of a Locally Tailored Evidence-based Chinese Smartphone Application in Management of Type 1 Diabetes Mellitus Aged 6-18 Years in Hong Kong - a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 1, 2021 (Actual)
Primary Completion Date
May 1, 2024 (Anticipated)
Study Completion Date
June 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chinese University of Hong Kong

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Moving into the era of electronic communication, it changes the way we shall engage our children and adolescents. According to data of the Census and Statistics Department of Hong Kong releases in 2019, more than 80% and up to 99.4% of those aged 10-14 years, and aged 15-24 years respectively had a mobile phone device. A recent survey carried by Kebede et al. (2019) had shown that using diabetes apps was positively associated with self-care behavior in type 1 and type 2 diabetes mellitus (DM). A systematic review carried in Spain by Quevedo Rodríguez et al. (2018) had found most of the available smartphone apps lacked quality certification and very few provide scientific references on their content. In Hong Kong, there is currently no Chinese smartphone application targeting for the pediatric type 1 population, therefore, most of the education is based on face-to-face or telephone communication with the diabetic nurse and endocrinologists in limited encounters. For families or patients with limited command of English language, apart from one adult oriented DM information smartphone application, the chance of having on-hand mobile device support is truly limited. In light of this context, we shall first design an evidence-based locally tailored Chinese smartphone application for pediatric type 1 DM and then evaluate its effectiveness in improving management of type 1 DM in a robust manner. The main research question for this project is whether a self-help smartphone application in local Chinese language, tailored to include local clinical practice, culture and food spectrum, can improve diabetes control and psychological wellbeing in patients with type 1 diabetes mellitus aged 6-18 years. Eligible participants will be randomized to either using the smartphone application (on top of standard diabetic care) or continue standard diabetic care. The study aims to compare the difference between the two groups for their diabetic control and the psychological wellbeing.
Detailed Description
Objectives To evaluate the impact of a locally designed evidence-based Chinese smartphone application in improving type 1 diabetes mellitus management for aged 6-18 years in Hong Kong. Hypothesis Use of smartphone application can improve diabetes mellitus control and self-care ability, psychological wellbeing and quality of life. Design and subjects A single-blinded randomized controlled trial employing block randomization. Inclusion criteria: (1) Type 1 diabetes mellitus diagnosed for at least 6 months, (2) Aged 6-18 years, (3) HbA1c >/=6.0%, (4) Receiving DM care in Hong Kong. Exclusion criteria: (1) Lack of the ability to use a smartphone application, (2) Moderate to severe visual impairment, (3) Cannot read Chinese language. Aim for 57 participants in each of the control and intervention arms for a statistical power of 80%. Study instruments (1) HemoglobinA1c, (2) Time in range and frequency of hypoglycaemia by continuous glucose monitoring, (3) Chinese versions of PSC-35, PedsQL and DSMQ questionnaires. Interventions Use of the smartphone application for 6 months. Main outcome measures Primary outcomes include (1) HbA1c, (2) Time in range, (2) Frequency of hypoglycaemia. Secondary outcomes are scores of PSC-35, PedsQL and DSMQ. Data analysis and expected results Data to be analysed with intention-to-treat. A post hoc analysis is planned to capture data in the reduced application usage group. Generalized estimating equation will be employed to analyse the data involving within-subject covariance. Around 10% dropout rate assumed. A statistically significant result is defined by a 2-tailed alpha level of 0.05.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type1 Diabetes Mellitus

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
114 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention Arm - Use of the new smartphone application for T1DM
Arm Type
Active Comparator
Arm Description
The use of the locally designed smartphone application for T1DM for 6 months, which contained the following domains: Type 1 DM self-management information and decision-making algorithm Carbohydrate counting information on local food in Hong Kong DM day-to-day troubleshooting psychosocial scenarios Game-based interactive tools for DM knowledge enhancement Usage tracking for each domain of the smartphone application Individual participant identification and access code (known to research assistant)
Arm Title
Control Arm - Standard diabetic education
Arm Type
Placebo Comparator
Arm Description
Received standard diabetic care (diabetic nurse education and regular follow-ups) with optional use of an existing smartphone application for general diabetic information for both adult and pediatric population (that encompasses both information for type 1 and type 2 DM)
Intervention Type
Device
Intervention Name(s)
Intervention arm - A new smartphone application for pediatric type 1 DM
Intervention Description
An evidence-based locally tailored Chinese smartphone application for pediatric type 1 DM
Intervention Type
Other
Intervention Name(s)
Standard diabetic eduction
Intervention Description
Received standard diabetic care (diabetic nurse education and regular follow-ups) with optional use of an existing smartphone application for general diabetic
Primary Outcome Measure Information:
Title
HbA1c
Description
A decrease of 0.5% is considered significant
Time Frame
6 months (Assessed at 3 months and 6 months from start of intervention)
Title
CGM data
Description
Time in range, glycemic variability and percentage of hypoglycemia as documented by continuous glucose monitoring (for a period of 2 weeks) at baseline and at the end of study.
Time Frame
6 months
Title
Self/Parent-reported questionnaires on hypoglycemia frequency
Description
Self/Parent-reported questionnaires on hypoglycemia frequency, the lowest glucose reading during hypoglycemia and number of severe hypoglycemia requiring glucagon use - to be performed at baseline and at the end of study.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
The PSC-35 (Pediatric Symptom Checklist-35 items) questionnaires
Description
The PSC-35 (Pediatric Symptom Checklist-35 items) questionnaires is employed to assess the psychological wellbeing at baseline and at the end of study.
Time Frame
6 months
Title
The Chinese version of the Diabetes Self-Management Questionnaire (DSMQ)
Description
The Chinese version of the Diabetes Self-Management Questionnaire (DSMQ) is employed to assess the diabetes self-management behavior at baseline and at the end of study. The data on the questionnaire's use in youths or children are not available yet. We will interpret with caution for those questions not entirely applicable to participants <18 years.
Time Frame
6 months
Title
The Chinese version of the Pediatric Quality of Life Inventory 4.0 plus the 3.0 diabetes module
Description
The Chinese version of the Pediatric Quality of Life Inventory 4.0 plus the 3.0 diabetes module to be filled in at baseline and at the end of study.Diabetes module will not be required for participants with ages 5-7 years as Chinese version is currently not available.
Time Frame
6 months
Title
Self/Parent-reported questionnaires to assess on carbohydrate counting accuracy on local Hong Kong diet at baseline and at the end of study
Description
Self/Parent-reported questionnaires to assess on carbohydrate counting accuracy on local Hong Kong diet at baseline and at the end of study
Time Frame
6 months
Title
Self-reported smartphone application usage satisfaction
Description
Self-reported smartphone application usage satisfaction to be filled at 3 months and the end of study.
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Known type 1 DM diagnosed for at least 6 months Aged 6-18 years HbA1c >/= 6.0% in the preceding 6 months prior to recruitment Receiving DM care in Hong Kong Exclusion Criteria: Lack of the ability to use a smartphone application despite an introduction session the smartphone application intended for this study Moderate to severe visual impairment that may affect the smartphone application usage Cannot read Chinese language.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Samathan Lee
Phone
+852 5741 3307
Email
llk051a@ha.org.hk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Samathan Lee
Organizational Affiliation
Hong Kong Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hong Kong Children's Hospital
City
Hong Kong
Country
Hong Kong
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Samantha Lee
Phone
+852 5741 3307
Email
llk051a@ha.org.hk

12. IPD Sharing Statement

Learn more about this trial

Chinese Smartphone App for 6-18 Years With T1DM - RCT

We'll reach out to this number within 24 hrs